Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Marinus (MRNS)
NASDAQ:MRNS
Marinus (MRNS) Stock Price & Analysis
946 Followers
MRNS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.47 - $9.82
Previous Close$9.13
Volume17.66K
Average Volume (3M)672.70K
Market Cap
$470.10M
Enterprise Value$333.80M
Total Cash (Recent Filing)$199.20M
Total Debt (Recent Filing)$71.50M
Price to Earnings (P/E)-15.1
Beta1.28
Next Earnings
Aug 10, 2023EPS Estimate
-$0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.60
Shares Outstanding50,547,986
10 Day Avg. Volume728,564
30 Day Avg. Volume672,703
Standard Deviation0.25
R-Squared0.06
Alpha0.00500
Financial Highlights & Ratios
Price to Book (P/B)4.78
Price to Sales (P/S)123.49
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-71.26
Enterprise Value/Gross Profit19.60
Enterprise Value/Ebitda-14.90
Forecast
1Y Price Target
$23.09Price Target Upside148.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Marinus News
Stock Analysis & IdeasBillionaire Steve Cohen Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRNS FAQ
What was Marinus’s price range in the past 12 months?
Marinus lowest stock price was $3.46 and its highest was $9.82 in the past 12 months.
What is Marinus’s market cap?
Currently, no data Available
When is Marinus’s upcoming earnings report date?
Marinus’s upcoming earnings report date is Aug 10, 2023 which is in 62 days.
How were Marinus’s earnings last quarter?
Marinus released its earnings results on May 11, 2023. The company reported -$0.67 earnings per share for the quarter, beating the consensus estimate of -$0.731 by $0.061.
Is Marinus overvalued?
According to Wall Street analysts Marinus’s price is currently Undervalued.
Does Marinus pay dividends?
Marinus does not currently pay dividends.
What is Marinus’s EPS estimate?
Marinus’s EPS estimate is -$0.72.
How many shares outstanding does Marinus have?
Marinus has 50,547,985 shares outstanding.
What happened to Marinus’s price movement after its last earnings report?
Marinus reported an EPS of -$0.67 in its last earnings report, beating expectations of -$0.731. Following the earnings report the stock price went down -3.34%.
Which hedge fund is a major shareholder of Marinus?
Among the largest hedge funds holding Marinus’s share is Woodline Partners LP. It holds Marinus’s shares valued at 11M.
---
Marinus Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.09 (148.28% Upside)
$23.09 (148.28% Upside)
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.5%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.45%
12-Months-Change
Fundamentals
Return on Equity
-56.08%
Trailing 12-Months
Asset Growth
61.08%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Marinus
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.
---
Top 5 ETFs holding MRNS
iShares Biotechnology ETF
$2.70M
iShares NASDAQ US Biotechnology UCITS ETF
$195.04K
Invesco Nasdaq Biotechnology ETF
$7.72K
Up to five ETFs with an Outperform Smart Score that hold MRNS. The ETFs are listed according to market value of MRNS within the ETF
---
---